Chemoinformaics analysis of Hentriacontane-12,14-dione
Molecular Weight | 464.819 | nRot | 28 |
Heavy Atom Molecular Weight | 404.339 | nRig | 2 |
Exact Molecular Weight | 464.459 | nRing | 0 |
Solubility: LogS | -6.431 | nHRing | 0 |
Solubility: LogP | 11.199 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 93 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 60 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 31 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 93.3816 |
nHD | 0 | BPOL | 61.9284 |
QED | 0.085 |
Synth | 1.908 |
Natural Product Likeliness | 0.421 |
NR-PPAR-gamma | 0.97 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -5.319 |
MDCK | 0.00000471 |
BBB | 0.003 |
PPB | 0.9734 |
VDSS | 1.479 |
FU | 0.0062 |
CYP1A2-inh | 0.041 |
CYP1A2-sub | 0.15 |
CYP2c19-inh | 0.118 |
CYP2c19-sub | 0.042 |
CYP2c9-inh | 0.041 |
CYP2c9-sub | 0.984 |
CYP2d6-inh | 0.043 |
CYP2d6-sub | 0.014 |
CYP3a4-inh | 0.218 |
CYP3a4-sub | 0.018 |
CL | 5.273 |
T12 | 0.238 |
hERG | 0.375 |
Ames | 0.009 |
ROA | 0.011 |
SkinSen | 0.964 |
Carcinogencity | 0.027 |
EI | 0.917 |
Respiratory | 0.978 |
NR-Aromatase | 0.04 |
Antiviral | No |
Prediction | 0.571582 |